Development of FDA-Regulated Medical Products

Prescription Drugs, Biologics and Medical Devices

Elaine Whitmore

Hardcover
 224 Pages    2004
List $20.00
Member $20.00
Bulk Purchases
Request Information
Looking to purchase for a course or large group?
 

NOTE: There is a new edition of this book now available.

Many changes to the classification and regulation of prescription drugs, biologics, and medical devices have occurred since the previous edition of this book was published in 1997 under the title Product Development Planning for Health Care Products Regulated by the FDA. This revised edition includes: updated facts and figures; expansion of subjects that have grown more critical, such as clinical outcomes, human factors, and marketing objectives; and additional new topics such as the role of product development in hazard analysis, recalls, and product liability. The author also covers the Food and Drug Administrations Modernization Act (FDAMA), along with discussions on Intellectual Property, Pharmacoeconomics, and Technological and Medical Trends.


FROM THE FOREWORD TO Development of FDA-Regulated Medical Products

"As a business leader in the pharmaceutical industry whose career has been intimately tied to the product development process, I find Development of FDA-Regulated Medical Products to be comprehensive, inclusive and well organized."

       - Carrie S. Cox, President, Global Pharmaceuticals
Schering-Plough


Customer Reviews:     Please log in or register to comment.    FAQ

Rating
(0) Customer Reviews

Featured advertisers




ASQ is a global community of people passionate about quality, who use the tools, their ideas and expertise to make our world work better. ASQ: The Global Voice of Quality.